Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Apr 22 04:00PM ET
Dollar change
Percentage change
Index- P/E- EPS (ttm)-76.57 Insider Own4.76% Shs Outstand0.53M Perf Week-0.62%
Market Cap0.85M Forward P/E- EPS next Y-31.56 Insider Trans0.00% Shs Float0.51M Perf Month-27.27%
Income-8.95M PEG- EPS next Q-7.60 Inst Own2.08% Short Float2.96% Perf Quarter-57.56%
Sales0.00M P/S- EPS this Y11.41% Inst Trans-70.73% Short Ratio0.18 Perf Half Y-67.48%
Book/sh5.44 P/B0.29 EPS next Y-4.75% ROA-146.30% Short Interest0.02M Perf Year-97.45%
Cash/sh5.72 P/C0.28 EPS next 5Y- ROE-202.15% 52W Range1.56 - 72.00 Perf YTD-64.60%
Dividend Est.- P/FCF- EPS past 5Y42.24% ROI-307.90% 52W High-97.78% Beta-
Dividend TTM- Quick Ratio4.50 Sales past 5Y0.00% Gross Margin- 52W Low2.56% ATR (14)0.23
Dividend Ex-Date- Current Ratio4.50 EPS Y/Y TTM-86.18% Oper. Margin0.00% RSI (14)33.88 Volatility13.83% 10.68%
Employees2 Debt/Eq0.00 Sales Y/Y TTM- Profit Margin- Recom1.00 Target Price300.00
Option/ShortNo / Yes LT Debt/Eq0.00 EPS Q/Q-120.70% Payout- Rel Volume0.24 Prev Close1.61
Sales Surprise- EPS Surprise- Sales Q/Q- Earnings- Avg Volume81.76K Price1.60
SMA20-14.33% SMA50-35.05% SMA200-67.45% Trades Volume20,809 Change-0.62%
Mar-06-24 04:15PM
Mar-04-24 09:15AM
Mar-01-24 08:00AM
Jan-11-24 08:00AM
Jan-10-24 08:00AM
11:03AM Loading…
Dec-20-23 11:03AM
Dec-18-23 08:00AM
Nov-20-23 12:38PM
Nov-17-23 08:37AM
Nov-16-23 04:43PM
Sep-26-23 08:00AM
Sep-15-23 03:02AM
Sep-13-23 05:01AM
Aug-15-23 08:43AM
11:30PM Loading…
Jun-14-23 11:30PM
Jun-08-23 06:15AM
Jun-06-23 01:00PM
May-16-23 07:20AM
Apr-11-23 08:27AM
Mar-17-23 06:29AM
Jan-26-23 08:30AM
Nov-15-22 06:10AM
Oct-25-22 08:00AM
Oct-13-22 09:00AM
Oct-12-22 04:05PM
Oct-07-22 10:52AM
Sep-15-22 06:20AM
07:23AM Loading…
Jun-07-22 07:23AM
Mar-23-22 08:00AM
Mar-18-22 07:25AM
Mar-07-22 07:00AM
Feb-24-22 06:00AM
Jan-10-22 03:50PM
Jan-05-22 08:30AM
Nov-17-21 06:43AM
Nov-16-21 06:49AM
Nov-10-21 09:15AM
Nov-02-21 07:26AM
Oct-18-21 08:30AM
Oct-15-21 12:00PM
Oct-13-21 01:43PM
Bone Biologics Corp. operates as a medical device company. engages in the research and development of bone regeneration in spinal fusion. Its product is Nell-1, which is an osteostimulative recombinant protein that provides target specific control over bone regeneration. Its platform technology has application in delivering improved outcomes in the surgical specialties of spinal, orthopedic, general orthopedic, plastic reconstruction, neurosurgery, interventional radiology, and sports medicine. The company was founded by Eric Kang Ting, Chia Soo and Benjamin Wu in 2004 and is headquartered in Burlington, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Walsh Deina HChief Financial OfficerSep 13 '23Buy0.648,0005,12015,000Sep 14 11:08 AM
Frelick JeffChief Executive OfficerSep 11 '23Buy0.699,5006,53017,204Sep 12 11:34 AM
Walsh Deina HChief Financial OfficerSep 06 '23Buy0.717,0004,9677,000Sep 07 10:45 AM
Frelick JeffChief Executive OfficerAug 31 '23Buy0.667,6005,0207,704Sep 05 05:05 PM